• Damora Therapeutics granted options covering 135,400 ordinary shares to three newly hired, non-executive employees on Sept. 1, 2026.
• Options carry a 10-year term with an exercise price of USD 28.18 per share.
• Vesting starts with 25% after one year, then continues in equal monthly installments over the next 36 months.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Damora Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609030800PRIMZONEFULLFEED9820519) on September 03, 2026, and is solely responsible for the information contained therein.